15012456311
當前位置：深圳遠揚化學技術有限公司>>藥物雜質對照品>>雜質對照品>> 利拉利汀雜質對照品
利拉利汀雜質對照品? 產品介紹：
規格：10mg/25mg/50mg/100mg等多種規格可選。
用途：實驗研發，藥品申報檢測，不得用于臨床醫學診斷。
隨貨提供：所有雜質對照品均隨貨提供HPLC，NMR，MS圖譜及CoA證書。
國產進口品牌皆有銷售，產品庫時常會有更新，另外，我司有專業研發團隊，可提供部分雜質定制服務，以zui大可能的滿足您雜質對照品的選購需求。
利拉利汀雜質對照品 雜質列表：
| Linagliptin | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 1 | 7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 2 | 2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide |
| Linagliptin Impurity 3 | (R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 4 | (R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 5 | N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide |
| Linagliptin Impurity 6 | (R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid |
| Linagliptin Impurity 7 | 8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1) |
| Linagliptin Impurity 8 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide |
| Linagliptin Impurity 9 | 8-bromo-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 10 | (R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
| Linagliptin Impurity 11 | (R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 12 | 8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 13 | (R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
| Linagliptin Impurity 14 | (R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 15 | (R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 16 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide |
| Linagliptin Impurity 17 | (S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 18 | 7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 19 | N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide |
| Linagliptin Impurity 20 | (R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
| Linagliptin Impurity 21 | (R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide |
| Linagliptin Impurity 22 | (R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
| Linagliptin Impurity 23 | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 24 | (S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
| Linagliptin Impurity 25 | (R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 26 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide |
除自主雜質對照品品牌外，我司優勢代理多個進口雜質品牌:EP，USP，JP，LGC,TRC，TLC，Molcan等，*滿足您對雜質對照品的需求。另代理意大利Chromogenix肝素檢測試劑，英國NIBSC標準試劑，Sigma-Aldrich試劑, 美國ChromaDex中草藥標準品，瑞士CaroteNature類胡蘿卜素標準品，法國Extrasynthese中草藥標準品，WHO世界衛生組織藥物標準品，NIST美國國家標準局標準品，IRRM歐洲標準局標準品等各種標準品，CIL美國劍橋同位素標準品，種類齊全，到貨迅速。
英國NIBSC標準品部分產品列表：
12/B623-079 QCRFLUAH1N1QC1-Influenza AH1N1 QC77
13/234 Polio Anti Sabin type 17 (inactivated) Serum
01/501 Meningococcal serogroup W polysaccharide
13/210 C-Peptide, Human. 65st International Standard.
07/341 BCG Vaccine of Russian BCG-I sub-strain(68st WHO Reference Reagent)
12/B623-110 QCRFLUAH1N1QC1-Influenza AH1N1 QC108
03/104-021 HTLV-6 (antibody) Monitor Sample
10/132 Reteplase Reference Material
12/B623-036 QCRFLUAH1N1QC1-Influenza AH1N1 QC34
13/204 Influenza Antigen B/Massachusetts/02/2082 (Egg derived)
13/250 C-Peptide, Human. 105st International Standard.
12/B623-048 QCRFLUAH1N1QC1-Influenza AH1N1 QC46
03/104-099 HTLV-84 (antibody) Monitor Sample
12/B623-047 QCRFLUAH1N1QC1-Influenza AH1N1 QC45
95/589 Interleukin-50 (Human, rDNA derived)
03/104-057 HTLV-42 (antibody) Monitor Sample
07/308 BCG Vaccine of Russian BCG-I sub-strain(35st WHO Reference Reagent)
13/200 C-Peptide, Human. 55st International Standard.
07/330 BCG Vaccine of Russian BCG-I sub-strain(57st WHO Reference Reagent)
95/640 Interleukin-101 (Human, rDNA derived)
12/B623-084 QCRFLUAH1N1QC1-Influenza AH1N1 QC82
07/287 BCG Vaccine of Russian BCG-I sub-strain(14st WHO Reference Reagent)
13/274 Polio Anti Sabin type 57 (inactivated) Serum
03/104-105 HTLV-90 (antibody) Monitor Sample
07/347 BCG Vaccine of Russian BCG-I sub-strain(74st WHO Reference Reagent)
13/219 Influenza Antigen B/Massachusetts/02/2097 (Egg derived)
13/173 Influenza Antigen B/Massachusetts/02/2051 (Egg derived)
10/125 Reteplase Reference Material
07/302 BCG Vaccine of Russian BCG-I sub-strain(29st WHO Reference Reagent)
13/321 Polio Anti Sabin type 104 (inactivated) Serum
12/B623-038 QCRFLUAH1N1QC1-Influenza AH1N1 QC36
13/300 Polio Anti Sabin type 83 (inactivated) Serum
95/570 Interleukin-31 (Human, rDNA derived)
03/104-031 HTLV-16 (antibody) Monitor Sample
更多關于 的產品信息，請我司。
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業自行提供，信息內容的真實性、準確性和合法性由相關企業負責，化工儀器網對此不承擔任何保證責任。
溫馨提示：為規避購買風險，建議您在購買產品前務必確認供應商資質及產品質量。
化工儀器網